Efficacy of a stepped care approach to deliver cognitive-behavioral therapy for insomnia in cancer patients: a noninferiority randomized controlled trial.


Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
12 11 2021
Historique:
received: 22 01 2021
revised: 05 05 2021
pubmed: 7 7 2021
medline: 18 3 2022
entrez: 6 7 2021
Statut: ppublish

Résumé

Cognitive-behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment for cancer-related insomnia, but its accessibility is very limited in routine care. A stepped care approach has been recommended as a cost-effective way to make CBT-I more widely accessible. However, no controlled study has yet been published about the efficacy of this approach. The goal of this noninferiority randomized controlled trial (RCT) was to compare the short and long-term efficacy of a stepped care CBT-I (StepCBT-I) to a standard face-to-face CBT-I (StanCBT-I). A total of 177 cancer patients were randomized to: (1) StanCBT-I (6 face-to-face CBT-I sessions; n = 59) or (2) StepCBT-I (n = 118). In the StepCBT-I group, patients with less severe insomnia first received a web-based CBT-I (n = 65), while those with more severe insomnia received 6 face-to-face CBT-I sessions (n = 53). In both cases, patients could receive up to three booster sessions of CBT-I if they still had insomnia symptoms following this first step. Results indicated that the Step-CBT-I group showed an Insomnia Severity Index score reduction and a sleep efficiency (on a sleep diary) increase that was not significantly inferior to that of StanCBT-I at all post-treatment time points. Analyses of secondary outcomes indicated significant time effects (ps < .001) and no significant group-by-time interactions (ps from .07 to .91) on other sleep diary parameters, sleep medication use, depression, anxiety, fatigue, and quality of life scores. The efficacy of stepped care CBT-I is not inferior to that of a standard face-to-face intervention and is a valuable approach to making this treatment more widely accessible to cancer patients. ClinicalTrials.gov Identifier: NCT01864720 (https://clinicaltrials.gov/ct2/show/NCT01864720?term=Savard&draw=2&rank=6; Stepped Care Model for the Wider Dissemination of Cognitive-Behavioural Therapy for Insomnia Among Cancer Patients).

Identifiants

pubmed: 34228123
pii: 6316025
doi: 10.1093/sleep/zsab166
pmc: PMC8598200
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01864720']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : #125968
Pays : Canada

Informations de copyright

© Sleep Research Society 2021. Published by Oxford University Press on behalf of the Sleep Research Society.

Références

Sleep Med Rev. 2016 Dec;30:1-10
pubmed: 26615572
J Consult Clin Psychol. 2000 Aug;68(4):549-55
pubmed: 10965629
Sleep Med. 2020 Nov;75:315-325
pubmed: 32950013
Sleep. 2009 Dec;32(12):1549-58
pubmed: 20041590
Psychooncology. 2007 Nov;16(11):1028-38
pubmed: 17352006
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Clin Sleep Med. 2013 Mar 15;9(3):227-34
pubmed: 23493468
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Br J Psychiatry. 2005 Jan;186:11-7
pubmed: 15630118
Health Psychol. 2015 Oct;34(10):983-91
pubmed: 25603417
Behav Sleep Med. 2021 Jan-Feb;19(1):70-82
pubmed: 31873040
Telemed J E Health. 2021 Apr;27(4):454-458
pubmed: 32926664
Contemp Clin Trials. 2009 Nov;30(6):513-22
pubmed: 19576299
Psychooncology. 2005 Jun;14(6):429-41
pubmed: 15376284
Qual Life Res. 1998 May;7(4):301-10
pubmed: 9610214
J Clin Oncol. 2010 Jan 10;28(2):292-8
pubmed: 19933917
Cancer. 2020 Jan 1;126(1):165-173
pubmed: 31550051
Sleep Med Rev. 2009 Feb;13(1):61-71
pubmed: 18952469
J Clin Oncol. 2008 Oct 1;26(28):4651-8
pubmed: 18591549
Sleep. 2014 Aug 01;37(8):1305-14
pubmed: 25083010
Sleep. 2018 Oct 1;41(10):
pubmed: 30053196
BMC Psychiatry. 2016 Nov 5;16(1):375
pubmed: 27816065
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Sleep Med Rev. 2015 Feb;19:17-28
pubmed: 25104471
J Pers Assess. 1998 Dec;71(3):349-67
pubmed: 9933941
Sleep. 2011 May 01;34(5):601-8
pubmed: 21532953
Support Care Cancer. 2013 Oct;21(10):2695-706
pubmed: 23708820
Clin Trials. 2007;4(3):286-91
pubmed: 17715258
Psychooncology. 2014 Jun;23(6):679-84
pubmed: 24458543
J Gen Intern Med. 2018 Jun;33(6):955-962
pubmed: 29619651
Twin Res Hum Genet. 2019 Jun;22(3):140-146
pubmed: 31203833
Behav Ther. 2016 Mar;47(2):166-83
pubmed: 26956650
Neuropsychiatr Dis Treat. 2014 Jun 18;10:1113-24
pubmed: 24971014
J Clin Oncol. 2009 Nov 1;27(31):5233-9
pubmed: 19738124
Psychol Med. 2018 Jul;48(10):1644-1654
pubmed: 29095133
Pediatr Blood Cancer. 2020 Sep;67(9):e28506
pubmed: 32568460
Depress Anxiety. 2011 Apr;28(4):314-23
pubmed: 21381157
J Clin Oncol. 2005 Sep 1;23(25):6083-96
pubmed: 16135475
Qual Life Res. 1997 Mar;6(2):103-8
pubmed: 9161109
J Sleep Res. 2020 Apr;29(2):e12967
pubmed: 31856367
Psychol Med. 2015 Jan;45(2):231-46
pubmed: 25065653
J Clin Oncol. 2011 Sep 10;29(26):3580-6
pubmed: 21825267
J Nerv Ment Dis. 1982 Apr;170(4):224-30
pubmed: 7062009
Sleep. 2016 Apr 01;39(4):813-23
pubmed: 26715229
Telemed J E Health. 2021 Jul;27(7):709-711
pubmed: 33297849

Auteurs

Josée Savard (J)

School of Psychology, Université Laval, Québec, Canada.
CHU de Québec-Université Laval Research Center, Québec, Canada.
Université Laval Cancer Research Center, Québec, Canada.

Hans Ivers (H)

School of Psychology, Université Laval, Québec, Canada.
CHU de Québec-Université Laval Research Center, Québec, Canada.
Université Laval Cancer Research Center, Québec, Canada.

Marie-Hélène Savard (MH)

CHU de Québec-Université Laval Research Center, Québec, Canada.
Université Laval Cancer Research Center, Québec, Canada.

Charles M Morin (CM)

School of Psychology, Université Laval, Québec, Canada.
CHU de Québec-Université Laval Research Center, Québec, Canada.
CERVO Brain Research Centre, Québec, Canada.

Aude Caplette-Gingras (A)

Université Laval Cancer Research Center, Québec, Canada.
Centre des maladies du sein, CHU de Québec-Université Laval, Québec, Canada.

Stéphane Bouchard (S)

Département de psychoéducation et de psychologie, Université du Québec en Outaouais et Centre de santé et services sociaux de l'Outaouais, Québec, Canada.

Guy Lacroix (G)

Département d'économique, Université Laval, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH